| Date | Time | Room | Session Title | Presentation Time | Topic | Role |
|---|---|---|---|---|---|---|
| 19/05/2023 | 08:10 to 10:40 | Di Cavalcanti |
Medical Medical Acute Lymphoblastic Leukemia (ALL) |
09:50 to 10:08 | The challenge in the treatment of T-ALL | Speaker |
| 19/05/2023 | 08:10 to 10:40 | Di Cavalcanti |
Medical Medical Acute Lymphoblastic Leukemia (ALL) |
10:15 to 10:33 | The most up-to-date CAR-T results in ALL: when, how, and who benefits the most? | Speaker |
| 19/05/2023 | 08:10 to 10:40 | Di Cavalcanti |
Medical Medical Acute Lymphoblastic Leukemia (ALL) |
10:08 to 10:15 | Q&A | Discussant |
| 19/05/2023 | 08:10 to 10:40 | Di Cavalcanti |
Medical Medical Acute Lymphoblastic Leukemia (ALL) |
10:33 to 10:40 | Q&A | Discussant |
| 20/05/2023 | 09:25 to 11:30 | Di Cavalcanti |
Medical Medical Indolent Lymphomas |
09:25 to 09:43 | Are we about to abandon transplantation in Mantle Cell Lymphoma? | Speaker |
| 20/05/2023 | 09:25 to 11:30 | Di Cavalcanti |
Medical Medical Indolent Lymphomas |
09:43 to 09:50 | Q&A | Discussant |
| 20/05/2023 | 09:25 to 11:30 | Di Cavalcanti |
Medical Medical Indolent Lymphomas |
10:15 to 10:33 | CAR-T therapy in Follicular Lymphoma and Mantle Cell Lymphoma: “une petite ou grande révolution” | Speaker |
| 20/05/2023 | 09:25 to 11:30 | Di Cavalcanti |
Medical Medical Indolent Lymphomas |
10:33 to 10:40 | Q&A | Discussant |